Skip to main content
Article thumbnail
Location of Repository

C-terminal fluorescent labeling impairs functionality of DNA mismatch repair proteins

By Angela Brieger, Guido Plotz, Inga Malena Hinrichsen, Sandra Passmann, Ronja Sophia Mercedes Adam and Stefan Zeuzem


The human DNA mismatch repair (MMR) process is crucial to maintain the integrity of the genome and requires many different proteins which interact perfectly and coordinated. Germline mutations in MMR genes are responsible for the development of the hereditary form of colorectal cancer called Lynch syndrome. Various mutations mainly in two MMR proteins, MLH1 and MSH2, have been identified so far, whereas 55% are detected within MLH1, the essential component of the heterodimer MutLα (MLH1 and PMS2). Most of those MLH1 variants are pathogenic but the relevance of missense mutations often remains unclear. Many different recombinant systems are applied to filter out disease-associated proteins whereby fluorescent tagged proteins are frequently used. However, dye labeling might have deleterious effects on MutLα's functionality. Therefore, we analyzed the consequences of N- and C-terminal fluorescent labeling on expression level, cellular localization and MMR activity of MutLα. Besides significant influence of GFP- or Red-fusion on protein expression we detected incorrect shuttling of single expressed C-terminal GFP-tagged PMS2 into the nucleus and found that C-terminal dye labeling impaired MMR function of MutLα. In contrast, N-terminal tagged MutLαs retained correct functionality and can be recommended both for the analysis of cellular localization and MMR efficiency

Topics: ddc:610
Year: 2012
OAI identifier:

Suggested articles


  1. (2011). A CRM1-dependent nuclear export pathway is involved in the regulation of MutLalpha subcellular localization.
  2. (2010). Analysis of an autoproteolytic activity of rice yellow mottle virus silencing suppressor P1.
  3. (2006). Analysis of the human MutLalpha.MutSalpha complex.
  4. (2009). Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndrome.
  5. (2005). C-terminal ECFP fusion impairs synaptotagmin 1 function: crowding out synaptotagmin 1.
  6. (2007). Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2.
  7. (2005). Characterization of the nuclear import of human MutLalpha.
  8. (2010). Cytoskeletal scaffolding proteins interact with Lynch-Syndrome associated mismatch repair protein MLH1.
  9. (2003). de la Chapelle A
  10. (2003). Dimerization of MLH1 and PMS2 limits nuclear localization of MutLalpha.
  11. (2002). Evidence for a direct association of hMRE11 with the human mismatch repair protein hMLH1.
  12. (2011). Evidence for classification of c.1852_1853AA.GC in MLH1 as a neutral variant for Lynch syndrome.
  13. (2009). Fluorescent proteins: a cell biologist’s user guide.
  14. (2006). Functional analysis of AP-2 alpha and mu2 subunits.
  15. (2002). Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system.
  16. (2009). Functional characterization of rare missense mutations in MLH1 and MSH2 identified in Danish colorectal cancer patients.
  17. (2005). Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1.
  18. (2009). Guarne A
  19. (2004). HNPCC mutation MLH1 P648S makes the functional protein unstable, and homozygosity predisposes to mild neurofibromatosis type 1.
  20. (2001). HNPCC mutations in the human DNA mismatch repair gene hMLH1 influence assembly of hMutLalpha and hMLH1-hEXO1 complexes.
  21. (2010). Identification of Lynch syndrome mutations in the MLH1-PMS2 interface that disturb dimerization and mismatch repair.
  22. (2003). Methylation-induced G(2)/M arrest requires a full complement of the mismatch repair protein hMLH1.
  23. (2011). Missense variants in hMLH1 identified in patients from the German HNPCC consortium and functional studies.
  24. (2006). Mutations in the MutSalpha interaction interface of MLH1 can abolish DNA mismatch repair.
  25. (2003). N-terminus of hMLH1 confers interaction of hMutLalpha and hMutLbeta with hMutSalpha.
  26. (2003). Pathogenicity of the hereditary colorectal cancer mutation hMLH1 del616 linked to shortage of the functional protein.
  27. (2008). Recruitment of mismatch repair proteins to the site of DNA damage in human cells.
  28. (2001). Structure and function of the N-terminal 40 kDa fragment of human PMS2: a monomeric GHL ATPase.
  29. (2004). Structure of the MutL C-terminal domain: a model of intact MutL and its roles in mismatch repair.
  30. (2008). The PMS2 subunit of human MutLalpha contains a metal ion binding domain of the irondependent repressor protein family.
  31. (2007). Thymosin beta 4 expression and nuclear transport are regulated by hMLH1.
  32. (2002). Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants.
  33. (2006). Truncation of the C-terminus of human MLH1 blocks intracellular stabilization of PMS2 and disrupts DNA mismatch repair.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.